Abstract:Methylsulfonylmethane (MSM) is a common dietary supplement mainly used for inflammatory disorders as well as MSM had shown anti-tumor effects on different types of cancers. However, the glioma cell line has not been tested against MSM, and we are reporting it in our study for the first time. This research used an in silico study in which sphingosine kinase 1(SphK1) is used as a therapeutic target which is associated with Glioblastoma multiforme(GBM). SphK1 is pivotal enzyme for sphingolipid metabolism whose high expression level is thought to be associated with cancer alongside other inflammatory diseases and it is a potential drug target for various types of cancer. First, in silico analysis was executed to evaluate the inhibitory effect of MSM on SphK1.Then we further observed the anti-tumor activities of MSM on the C6 glioma cell line. During in silico investigation at the initial stage, we performed molecular docking with Auto Dock Vina followed by molecular dynamics simulation at 100ns with Gromacs Software Package. MSM binds with SphK1 with a docked score of -2.1 kcal mol1. During molecular dynamics simulation complex maintain stability at 10ns but we ran simulation till 100ns to confirm the stability. We performed in depth analysis which includes post trajectory analysis like free energy landscape (FEL), principal constant analysis (PCA) with kernel density (KDE)estimation plots as well as probability distribution plots. Even molecular dynamics simulation shows stability, compactness and interaction of MSM with Sphk1, we calculated MMPBSA binding energy calculation is -13.922 +/- 19.518 kJ/mol- The viability and cellular metabolic activity of the C6 glioma in the presence of MSM showed 393.459 mM /ml of MSM reduced cell viability by 50% (CTC50) value in dose dependent manner. Further analysis like DNA fragmentation assay and Acridine orange and ethidium bromide (AO/EB) staining were carried out, which clearly depicts MSM inducing apoptosis in C6 gliomas. Based on in silico and in vitro results, for the first time, we are reporting it in our study, and we conclude that MSM acts as a potential inhibitor for SphK1 as well as inhibits the growth of glioma cells and acts as a potential dietary supplement for the management of GBM which can cross the blood-brain barrier (BBB) and not toxic to cells even at high dose.

Methylsulfonylmethane: A Potential Dietary Supplement targeting sphingosine kinase 1 involved in Glioblastomamultiforme

S100B Suppression Alters Polarization of Infiltrating Myeloid-Derived Cells in Gliomas and Inhibits Tumor Growth.

IMPS-44S100B INHIBITION WITH DULOXETINE, A SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR, ALTERS MACROPHAGE POLARIZATION AND ABROGATES GLIOMA GROWTH IN MICE

New Protocol-Guided Exploitation of a Lysosomal Sulfatase Inhibitor to Suppress Cell Growth in Glioblastoma Multiforme

Identification of Imidazo[4,5-C]pyridin-2-one Derivatives As Novel Src Family Kinase Inhibitors Against Glioblastoma.

Cnsc-49. Elucidating Therapeutic Potential Of Usp1 Inhibition In Diffuse Midline Gliomas

Investigating potential of cholic acid, syringic acid, and mangiferin as cancer therapeutics through sphingosine kinase 1 inhibition

Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-B/IL-6/STAT3 and JNK/PTX3 pathways

Guggulsterone inhibits migration and invasion through proteasomal and lysosomal degradation in human glioblastoma cells

Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa: Advancements in computational therapeutics

Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF- κ B /IL-6/STAT3 and JNK/PTX3 pathways

Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling

Immu-24. Glioblastoma Enriched Glycosphingolipids Modulate The Function Of Human Inkt Cells

Assessing fatty acid-induced lipotoxicity and its therapeutic potential in glioblastoma using stimulated Raman microscopy

Saikosaponin D Inducing Apoptosis and Autophagy through the Activation of Endoplasmic Reticulum Stress in Glioblastoma

Inhibitory effects of Gracilaria edulis and Gracilaria salicornia against the MGMT and VEGFA biomarkers involved in the onset and advancement of glioblastoma using in silico and in vitro approaches

Csig-32. Modulation Of Hallmarks Of Glioblastoma Multiforme By Bioactive Phytochemicals: A Preclinical Mechanistic Evaluation

Methylsulfonylmethane induces caspase-dependent apoptosis in acute myeloid leukemia cell lines

Dddr-06. Enhancing Glioblastoma Treatment With Molybdenum Disulfide(Mos2) Nanomaterials And Ultrasound-Triggered Tumor Growth Inhibition

Novel multi-drugs incorporating hybrid-structured nanofibers enhance alkylating agent activity in malignant gliomas

The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells